{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:41:54Z","timestamp":1787917314811,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cardfail.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T09:17:38Z","timestamp":1663406258000},"page":"1683-1691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9464-6934","authenticated-orcid":false,"given":"FARHAD","family":"SAMI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PRAKASH","family":"ACHARYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GRACE","family":"NOONAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEVEN","family":"MAURIDES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANAS ABUDAN","family":"AL-MASRY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUHAIB","family":"BAJWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIKHIL","family":"PARIMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ILHAM","family":"BODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTINA","family":"TRAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMANDEEP","family":"GOYAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IOANNIS","family":"MASTORIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TARUN","family":"DALIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW","family":"SAUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADRIAN VAN","family":"BAKEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZUBAIR","family":"SHAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.08.007_bib0001","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the","volume":"6","author":"Heidenreich","year":"2013","journal-title":"American Heart Association. Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0002","first-page":"e146","article-title":"Heart disease and stroke statistics-2017 update: a report from the","volume":"135","author":"Benjamin","year":"2017","journal-title":"American Heart Association. Circulation"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0003","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jchf.2020.01.014","article-title":"Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches","volume":"8","author":"Truby","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0004","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ahj.2007.10.020","article-title":"Characteristics of \"stage D\" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)","volume":"155","author":"Costanzo","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0006","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/01.CIR.0000078349.43742.8A","article-title":"Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy","volume":"108","author":"Stevenson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCULATIONAHA.117.028747","article-title":"An unintended consequence of the 21st-century cures act for patients with heart failure","volume":"136","author":"Gilstrap","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0008","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.58.3.466","article-title":"Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure","volume":"58","author":"Leier","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0009","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0002-8703(80)90226-4","article-title":"Long-term benefit of dobutamine in patients with congestive cardiomyopathy","volume":"100","author":"Unverferth","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0011","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0012","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJM199812173392503","article-title":"A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators","volume":"339","author":"Cohn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0013","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure","volume":"9","author":"Hershberger","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00054187","article-title":"Intermittent infusion of dobutamine in the therapy of severe congestive heart failure\u2013long-term effects and lack of tolerance","volume":"6","author":"Erlemeier","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0017","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0009-9236(98)90092-3","article-title":"Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study","volume":"63","author":"Elis","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0018","doi-asserted-by":"crossref","first-page":"1096.e1","DOI":"10.1016\/j.ahj.2006.08.003","article-title":"Chronic inotropic therapy in end-stage heart failure","volume":"152","author":"Hauptman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0019","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0020","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cardfail.2021.06.006","article-title":"Chronic intravenous inotropic support as palliative therapy and bridge therapy for patients with advanced heart failure: a single-center experience","volume":"27","author":"Rao","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0021","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM198903163201101","article-title":"A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure","volume":"320","author":"DiBianco","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/FJC.0000000000000811","article-title":"Comparison of positive inotropic agents in the management of acute decompensated heart failure","volume":"75","author":"Kelly","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0023","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamacardio.2019.2081","article-title":"Palliative inotrope therapy: a narrative review","volume":"4","author":"Chuzi","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0024","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/phar.2091","article-title":"Guideline-directed medical therapy and survival following hospitalization in patients with heart failure","volume":"38","author":"Tran","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0026","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis","volume":"3","author":"Prins","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004675","article-title":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction","volume":"6","author":"Gilstrap","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0028","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-12-0033","article-title":"Low-dose \u03b2-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure","volume":"76","author":"Kobayashi","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0029","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1345\/aph.1M357","article-title":"Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure","volume":"43","author":"Jennings","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cardfail.2022.08.007_bib0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/mhj.2001.117605","article-title":"Carvedilol titration in patients with congestive heart failure receiving inotropic therapy","volume":"142","author":"Kumar","year":"2001","journal-title":"Am Heart J"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422007114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422007114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:48:24Z","timestamp":1761029304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916422007114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1071916422007114"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.08.007","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}